Table 1 Baseline clinical and demographic characteristics
Cohort (38 patients) | |
|---|---|
Gender (male/female) | 9/29 |
Age (y), mean ± SD (range) | 39.6 ± 7.3 (26–53) |
Disease duration (y), mean ± SD (range) | 12.0 ± 7.1 (2–31) |
EDSS score, median (range) | 2.0 (0–6) |
Previous ARR (1y/2y before), mean ± SD | 1.2 ± 0.5/0.8 ± 0.4 |
Previous use of ISs (yes/no) | 6/32 |
Type of ISs (MTX/CTX) | 5/1 |
Time from ISs suspension (y), mean ± SD (range) | 7.2 ± 2.1 (4–10) |
Previous use of DMDs (yes/no) | 35/3 |
Type of DMDs (IFNs/GA/both) | 17/5/13 |
DMDs therapy duration (y), mean ± SD (range) | 5.3 ± 3.9 (0.6–15) |